← Back
▲ BUY
7 / 10

Conviction

$ Value

$647K

Shares

1,000

Price

$647

Filed

Aug 13

Why this score? (7/10)
  • Open market buy (+3)
  • Trade value >= $250K (+1)
  • Cluster: 7 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Van Naarden Jacob

Title

EVP & Pres., Lilly Oncology

CIK

0001661254

Roles

Officer

Transaction Details

Transaction Date

2025-08-13

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

20,562

Footnotes

The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Filing Info

Accession No.

0000059478-25-000218

Form Type

4

Issuer CIK

0000059478

Van Naarden Jacob's History

Date Ticker Type Value
2026-02-09 LLY A $5.1M
2026-02-01 LLY M $0
2026-02-01 LLY F $2.0M
2026-02-01 LLY M $0
2025-08-13 LLY $647K

Other Insiders at LLY (90d)

Insider Bought Sold Last
Sulzberger Gabrielle 2026-04-20
Alvarez Ralph 2026-04-20
Fyrwald J Erik 2026-04-20
LUCIANO JUAN R 2026-04-20
Ricks David A
President, Chair, and CEO
2026-02-09
Zakrowski Donald A
SVP, Finance, & CAO
2026-02-16
Van Naarden Jacob
EVP,Pres LLY Oncology&HdCorpBD
2026-02-09
Hakim Anat
EVP, GC & Secretary
2026-02-09
Skovronsky Daniel
EVP, CS&PO & Pres. LRL
2026-02-09
Montarce Lucas
EVP & CFO
2026-02-16
Jonsson Patrik
EVP & President, LLY Int'l
2026-02-09
Yuffa Ilya
EVP&Pres, LLY USA&Global Capab
2026-02-09
Rau Diogo
EVP & CIDO
2026-02-09
Hernandez Edgardo
EVP & Pres., Mfg. Operations
2026-02-09
Dozier Eric
EVP, Chief People Officer
2026-02-19
Custer Kenneth L.
EVP & President, Card Met Hlth
2026-02-16
Brown Adrienne S
EVP, President LLY Imm
2026-02-16